HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

NCT02806505 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

Hoffmann-La Roche